文献速递乳腺MRUS

自动乳腺容积扫描仪(ABVS)与手持超声作为磁共振成像后二次检查程序的比较

Comparison between automated breast volume scanner (ABVS) versus hand-held ultrasound as a second look procedure after magnetic resonance imaging.
PubMed 文献 · Eur Radiol · 2017-01-24

本研究在7个月内前瞻性纳入131例1.5T乳腺MRI发现额外病灶的患者,分别行二次超声(SL-US)和二次自动乳腺容积扫描(SL-ABVS),由5名乳腺放射科医师盲法独立判读。SL-ABVS与SL-US对MRI病灶的检出率相当(69.3% vs 71.5%,P>0.05),判断病灶显著性(BI-RADS 3-5 vs 1-2)的一致性几乎完美(k=0.94),癌检出率分别为83.8%和87.0%。作者认为SL-ABVS有潜力在二次检查场景中替代SL-US。

要点

  • SL-ABVS与SL-US对MRI额外病灶的检出率相当(69.3% vs 71.5%)。
  • 两种方法判断病灶显著性的一致性几乎完美(k=0.94)。
  • SL-ABVS癌检出率83.8%,SL-US为87.0%,仅1/31例癌被SL-ABVS漏诊。

核心结论

  • SL-ABVS与SL-US在评估MRI病灶显著性方面几乎等效,癌检出率相当;SL-ABVS有潜力在二次检查场景中替代SL-US。

研究设计与样本

  • 前瞻性研究,7个月内纳入131例在1.5T乳腺MRI中发现额外病灶的患者,所有患者均行SL-US和SL-ABVS,由5名经验丰富的乳腺放射科医师在盲法下独立判读。

关键影像表现/征象

  • SL-ABVS对MRI病灶的检出率为69.3%,SL-US为71.5%(P>0.05,McNemar检验)。
  • 两种方法将MRI病灶判为显著(BI-RADS 3-5)与不显著(BI-RADS 1-2)的一致性几乎完美(k=0.94)。
  • SL-ABVS的癌检出率为83.8%,SL-US为87.0%,仅1/31例癌被SL-ABVS漏诊。

诊断标准与关键数值

  • 以BI-RADS 3-5为显著、BI-RADS 1-2为不显著,SL-ABVS与SL-US判断一致性k=0.94。
  • SL-ABVS对MRI病灶检出率69.3%,SL-US为71.5%。
  • SL-ABVS癌检出率83.8%,SL-US为87.0%。

临床应用与阅片要点

  • SL-ABVS与SL-US对MRI额外病灶的评估几乎等效,癌检出率相当。
  • SL-ABVS有潜力在二次检查场景中替代SL-US。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the agreement between automated breast volume scanner (ABVS) and conventional ultrasound (US) as a second-look (SL) tool for assessing additional findings found on MRI.

METHODS: Over a 7-month period, we prospectively assigned to SL-US and SL-ABVS all patients undergoing 1.5 T breast MRI in whom additional findings were found. Five experienced breast radiologists independently interpreted SL-US and SL-ABVS in blinded sessions to evaluate the detection rate of MRI findings and assign them to BI-RADS categories. We calculated the agreement between the two methods in assessing MRI findings as significant (BI-RADS 3-5) versus not significant (BI-RADS 1-2), as well as their cancer detection rate.

RESULTS: In a population of 131 patients, SL-ABVS and SL-US showed a comparable detection rate of MRI findings (69.3 vs. 71.5%) (p > 0.05; McNemar test), with an almost perfect agreement in assessing them as significant or not (k = 0.94). This translated into a comparably high cancer detection rate (83.8% for SL-ABVS vs. 87.0% for SL-US). Only 1/31 cancers was missed by SL-ABVS.

CONCLUSIONS: SL-ABVS and SL-US are nearly equivalent in assessing the significance of MRI findings, leading to a comparable cancer detection rate. SL-ABVS has the potential to replace SL-US in the SL scenario.

KEY POINTS: • SL-ABVS shows almost perfect agreement with SL-US in assessing MRI findings. • SL-ABVS shows a comparably high cancer detection rate with respect to SL-US. • SL-ABVS has the potential to replace SL-US in evaluating additional MRI findings.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Girometti R, Zanotel M, Londero V, et al. Comparison between automated breast volume scanner (ABVS) versus hand-held ultrasound as a second look procedure after magnetic resonance imaging. Eur Radiol. 2017. PMID: 28120030. doi:10.1007/s00330-017-4749-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。